PMC:7534795 / 60163-60419 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T412","span":{"begin":15,"end":17},"obj":"Disease"},{"id":"T413","span":{"begin":79,"end":81},"obj":"Disease"}],"attributes":[{"id":"A412","pred":"mondo_id","subj":"T412","obj":"http://purl.obolibrary.org/obo/MONDO_0005068"},{"id":"A413","pred":"mondo_id","subj":"T413","obj":"http://purl.obolibrary.org/obo/MONDO_0005252"}],"text":"ch as a recent MI, to reduce death rates as well as individuals with prevalent HF to reduce hospitalizations and number of mortalities (Sacks et al., 2017; Siscovick, et al., 2017).\nThe cardiovascular benefits of n-3 PUFAs could be attributed to their plei"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T360","span":{"begin":6,"end":7},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"ch as a recent MI, to reduce death rates as well as individuals with prevalent HF to reduce hospitalizations and number of mortalities (Sacks et al., 2017; Siscovick, et al., 2017).\nThe cardiovascular benefits of n-3 PUFAs could be attributed to their plei"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T200","span":{"begin":15,"end":17},"obj":"Chemical"},{"id":"T80020","span":{"begin":79,"end":81},"obj":"Chemical"},{"id":"T204","span":{"begin":217,"end":222},"obj":"Chemical"}],"attributes":[{"id":"A75397","pred":"chebi_id","subj":"T200","obj":"http://purl.obolibrary.org/obo/CHEBI_53620"},{"id":"A80533","pred":"chebi_id","subj":"T200","obj":"http://purl.obolibrary.org/obo/CHEBI_74704"},{"id":"A24539","pred":"chebi_id","subj":"T80020","obj":"http://purl.obolibrary.org/obo/CHEBI_141438"},{"id":"A42337","pred":"chebi_id","subj":"T80020","obj":"http://purl.obolibrary.org/obo/CHEBI_29228"},{"id":"A27220","pred":"chebi_id","subj":"T204","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"}],"text":"ch as a recent MI, to reduce death rates as well as individuals with prevalent HF to reduce hospitalizations and number of mortalities (Sacks et al., 2017; Siscovick, et al., 2017).\nThe cardiovascular benefits of n-3 PUFAs could be attributed to their plei"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T193","span":{"begin":79,"end":81},"obj":"Phenotype"}],"attributes":[{"id":"A193","pred":"hp_id","subj":"T193","obj":"http://purl.obolibrary.org/obo/HP_0001635"}],"text":"ch as a recent MI, to reduce death rates as well as individuals with prevalent HF to reduce hospitalizations and number of mortalities (Sacks et al., 2017; Siscovick, et al., 2017).\nThe cardiovascular benefits of n-3 PUFAs could be attributed to their plei"}

    2_test

    {"project":"2_test","denotations":[{"id":"33031856-28620111-84038928","span":{"begin":150,"end":154},"obj":"28620111"},{"id":"33031856-28289069-84038929","span":{"begin":175,"end":179},"obj":"28289069"}],"text":"ch as a recent MI, to reduce death rates as well as individuals with prevalent HF to reduce hospitalizations and number of mortalities (Sacks et al., 2017; Siscovick, et al., 2017).\nThe cardiovascular benefits of n-3 PUFAs could be attributed to their plei"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1790","span":{"begin":29,"end":34},"obj":"Disease"},{"id":"1791","span":{"begin":123,"end":134},"obj":"Disease"},{"id":"1805","span":{"begin":213,"end":222},"obj":"Chemical"},{"id":"1814","span":{"begin":186,"end":209},"obj":"Disease"}],"attributes":[{"id":"A1790","pred":"tao:has_database_id","subj":"1790","obj":"MESH:D003643"},{"id":"A1791","pred":"tao:has_database_id","subj":"1791","obj":"MESH:D003643"},{"id":"A1805","pred":"tao:has_database_id","subj":"1805","obj":"MESH:D015525"},{"id":"A1814","pred":"tao:has_database_id","subj":"1814","obj":"MESH:D002318"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ch as a recent MI, to reduce death rates as well as individuals with prevalent HF to reduce hospitalizations and number of mortalities (Sacks et al., 2017; Siscovick, et al., 2017).\nThe cardiovascular benefits of n-3 PUFAs could be attributed to their plei"}